Pharmaceutical Specialties, Inc. Launches Zinc Cleansing Bar
Rochester, MN (PRWEB) October 18, 2016 -- Dermatologist-recommended company, Pharmaceutical Specialties, Inc. (PSI), is excited to introduce Vanicream™ Z-Bar (Pyrithione Zinc 2%) to its extensive lineup of sensitive skin care products. The new cleansing bar contains 2% Pyrithione Zinc and is OTC medicated to help control and reduce symptoms associated with seborrheic dermatitis and dandruff. This powerful yet soothing cleanser provides relief for itching, redness, flaking, and scaling which may be associated with these and similar conditions.
“Our dedication to the sensitive skin community is unmatched. We go to great lengths in selecting ingredients that are safe, effective, and suitable for our customers and are excited to offer a new option for those who suffer from seborrheic dermatitis” said Grant Schuth, Pharmaceutical Specialties, Inc. Vice President and Chief Science Officer.
Want to avoid common chemical irritants? The Vanicream™ Z-Bar is free of dyes, fragrance and masking fragrance, lanolin, parabens and formaldehyde. It is soap-free, oil-free, pH neutral, and doesn’t clog pores. Additionally, the cleansing bar contains Vanicream™ Moisturizing Skin Cream to keep skin feeling soft and supple.
Look for Vanicream™ Z-Bar on store shelves in the coming months. You can also find more information and purchase Vanicream™ Z-Bar online: https://www.psico.com/product/vanicream-zinc-bar/
About Pharmaceutical Specialties, Inc.
Pharmaceutical Specialties, Inc. has been manufacturing products for sensitive skin since 1975. We strive to develop products that are superior in terms of quality, effectiveness, and value. All products are free of common chemicals found in ordinary skin care products including dyes, parabens, lanolin, formaldehyde, and gluten. To learn more about Pharmaceutical Specialties, Inc., please visit https://www.psico.com.
Mark Kaske, PHARMACEUTICAL SPECIALTIES, INC., http://www.Vanicream.com, +1 (800) 325-8232 Ext: 2458, [email protected]
Share this article